|K El Emam, H Sood: “Enabling COVID-19 Data Access Using Data Synthesis”, Privacy & Pandemics: Responsible Uses of Technology & Health Data; Future of Privacy Forum, October 27-28, 2020.|
|K. Ghazinour, S. Matwin, M. Sokolova: “Monitoring and recommending privacy settings in social networks.” EDBT/ICDT Workshops, 2013.|
|K. El Emam: “Risk-based de-identification of health information.” In Proceedings of the HHS Workshop on the HIPAA Privacy Rule’s De-identification Standard, 2010.|
|F. K. Dankar and K. El Emam: “A method for evaluating marketer re-identification risk.” In Proceedings of the 3rd International Workshop on Privacy and Anonymity in the Information Society, 2010.|
|M. Sokolova, K. El Emam, S. Rose, S. Chowdhury, E. Neri, E. Jonker, and L. Peyton: “Personal health information leak prevention in heterogeneous texts.” Biomedical Information Extraction International Workshop, published in “Adaptation of Language Resources and Technology to New Domains,” 2009.|
|M. Sokolova and K. El Emam: “Evaluation of Learning from Screened Positive Examples.” Accepted by the 3rd workshop on Evaluation Methods for Machine Learning, in conjunction with the 25th International Conference on Machine Learning, ICML, 2008.|
|K. El Emam: “A Multi-method evaluation of the practices of small software projects.” In S. Garcia, C. Graettinger, and K. Kost (eds.): Proceedings of the First International Research Workshop on Process Improvement in Small Settings, Pittsburgh, Technical Report CMU/SEI 2006-SR-001, 2006.|
|G. Melnik and K. El Emam: “Third International Workshop on Empirical Evaluation of Agile Methods (“The Data Workshop”).” Proceedings of XP/Agile Universe 2004, Lecture Notes in Computer Science, Vol. 3134, Springer Verlag: 188, 2004.|
|J. Daly, K. El Emam and J. Miller: “Multi-method research in software engineering.” In Proceedings of the Second International Workshop on Empirical Studies of Software Maintenance, 1997.|
|G. Perez, K. El Emam, and N. H. Madhavji: “Customising software process models.” In Proceedings of the 4th European Workshop on Software Process Technology, Springer-Verlag, 1995.|
|K. El Emam and N. H. Madhavji: “A method for instrumenting software evolution processes and an example application.” Presentation at the International Workshop on Software Evolution Processes and Measurements, Victoria, Canada, 1994.|
|N. H. Madhavji, K. El Emam, and T. Bruckhaus: “An on-going study of factors causing process evolution.” Presentation at the International Workshop on the Evolution of Software Processes, Quebec, Canada, 1993.|
|K. El Emam, N. H. Madhavji, and K. Toubache: “Empirically driven improvements of generic process models.” In Proceedings of the 8th International Software Process Workshop, 1993.|
Z. Azizi,S. Lindner, Y. Shiba, V. Raparelli, C. Norris, K. Kublickiene, M.Trinidad Herreror, A. Kautzky-Willer, P. Klimek, K. El Emam, L. Pilote, and the GOING-FWD Investigators: "A Comparison of Synthetic Data Generation and Federated Analysis for Performing an International Assessment of Gender Effects on Cardiovascular Health". Canadian Cardiovascular Society Abstracts, 38(10) Supplement 2: S119-S120, October 1, 2022.
Z. Azizi, T. Gisinger, P. Alipour, J. Harreiter, V. Raparelli, K. Kublickiene, M.T. Herreror, C.M. Norris, K. El Emam, L. Pilote, A. Kautzky-Willer, and the GOING-FWD Investigators: "Role of Sex and Gender in Access to Care and Cardiovascular Complications of Individuals with Diabetes Mellitus". Canadian Cardiovascular Conference, October 21-24, 2021. [Winner of Trainee Research Award (Clinical Section), and CIHR/ICHR Registration Bursaries]
Z. Azizi, V. Raparelli, C. Norris, K. Kublickiene, A. Kautzky-Willer, T.M. Herrero, K. El Emam, L. Pilote, and the GOING FWD Investigators: “The Association between Sex, Gender and Health Status of Stroke Survivors in the Canadian Population”. Organization for the Study of Sex Differences (OSSD) virtual Annual Meeting, May 3-6, 2021.
|Z. Azizi, Y. Shiba, P. Alipour, F. Maleki, V. Raparelli, C. Norris, R. Forghani, L. Pilote, K. El Emam, and the GOING FWD Investigators: “The Importance of Sex and Gender Factors for COVID-19 Vaccination: A Sex-stratified Analysis Using Machine Learning”. Organization for the Study of Sex Differences (OSSD) virtual Annual Meeting, May 3-6, 2021.|
|Z. Azizi, L. Pilote, V. Raparelli, C. Norris, K. Kublickiene, T.M. Herrero, A. Kautzky-Willer, K. El Emam, and the GOING FWD Investigators: “Sex, Gender and Cardiovascular Health, An analysis of Synthetic Data from a Population-Based Study”. Journal of the American College of Cardiology, 77(18_Supplement_1): 3258, 2021. American College of Cardiology 70th Annual Scientific Session, May 11, 2021.|
|Z. Azizi, V. Raparelli, C. Norris, K. El Emam, L. Pilote, On behalf of the GOING-FWD Investigators: “The Association Between Sex, Gender And Health Status Of Stroke Survivors In The Canadian Population”. Stroke, 52:AP259, 2021. International Stroke Conference, March 11, 2021.|
|Z. Azizi, T. Gisinger, U. Bender, V. Raparelli, C.M. Norris, K. Kublickiene, M.T. Herrero, K. El Emam, A. Kautzky-Willer, L. Pilote, GOING-FWD Investigators: |
“Abstract 16147: Sex, Gender Factors and Cardiovascular Health in Canadian and Austrian Populations”. Circulation, 142(Suppl_3):A16147-A, 2020. American Heart Association Congress 2020.
|Z. Azizi, U. Bender, C. Tadiri, C.M. Norris ,V. Raparelli, K. El Emam, L. Pilote: “Sex And Gender Factors and The Cardiovascular Health of Canadians”. Canadian Journal of Cardiology, Oct 1;36(10):S21, 2020. Canadian Cardiovascular Congress 2020.|
Mosquera L: "The generation of synthetic clinical trial data". ISPOR Europe Conference, Nov 2-6, 2019.
Mosquera L: "Experiences generating synthetic clinical trial data." Drug Information Association Global Clinical Trial Disclosure and Data Transparency Conference, Sep 19-20, 2019.
E. Moher and K. El Emam: “Get it right or obtain it correctly: The role of readability of consent forms in determining disclosure rates.” 2014 NAPCRG Annual Meeting, November 2014.
|A. Essex, K. El Emam, L. Arbuckle, M. Tucciarone: “Secure Record Linkage: Encrypt, match, analyze.” Statistics Canada International Methodology Symposium, October 2014.|
|K. El Emam, N. Corner, L. Arbuckle, B. Eze: “The De-Identification of a Large Electronic Medical Records Database for Secondary Analysis.” Center for Health Services and Policy Research, February 2014.|
|E. Moher and K. El Emam: “Threats to security: Ironic consequences of secure data collection in healthcare.” The Society for Judgment and Decision Making Annual Meeting, November 2013.|
|K. El Emam, L. Arbuckle: “Disclosing Small Geographic Areas while Protecting Privacy.” The Ontario Public Health Convention, April 4, 2013.|
|K. El Emam, L. Arbuckle: “A Risk-based Methodology to De-identify Protected Health Information for the Heritage Health Prize.” 2012 American Statistical Association Conference on Statistical Practice.|
|El Emam K: “Risk-based De-identification of Health Data.” 3rd North American Congress of Epidemiology, 2011.|
|El Emam K, Samet S, Earle C: “Secure Logistic Regression of Horizontally Partitioned Data for PharmacoVigilance.” 3rd North American Congress of Epidemiology, 2011.|
|Frescura A, Wong T, Mercer J, Mukhi Nizar S, Totten S, Jayaraman G, El Emam K, Babin C, Saginur R, Rodin R, Garber G, Samina Aziz, Kavanagh D: “Rapid Real Time Surveillance and Monitoring of Pandemic Influenza Severity & Associated Risk Factors Using Primary Care Electronic Medical Records (EMR).” CPhA’s 99th Annual National Conference Montréal 2011.|
|K. Murto, U. Schwarz, K. Chowdary, I. Abushahwan, G. Bryson, J. King, D. Moher, K. El Emam, and W. Splinter: “A survey: Technology in a pediatric care setting.” Annual Meeting of the Canadian Anesthesiologists’ Society, 2006. |
Awarded best paper in Ambulatory Anesthesia.
|V. Bykerk, C. Kitamura, G. Kraag, M. Bell, B. Haraoui, E. Keystone, and K. El Emam: “Establishment of a multicenter Canadian cohort of patients with early inflammatory arthritis enabled by a real time data collection tool.” Annual European Congress of Rheumatology, 2005.|
|C. Bombardier, S. Solway, A. Wilkins, K. El Emam, J. Lee, and A. Sadikali: “eRheum: Integrating electronic capture and reporting of patient self-report data into the practice management of adults with Rheumatoid Arthritis.” Conference of the Canadian Rheumatology Association, 2005.|
|K. El Emam: “The certification of eHealth software.” Canadian Society for Telehealth Conference, 2003.|
|PhUSE: PhUSE De-identification Standard, May 2015.|
|Institute of Medicine:Sharing Clinical Trial Data: Maximizing benefits, minimizing risk. National Academies Press, 2015.|
|Health Information Trust Alliance: HITRUST De-Identification Framework, 2015.|
K. El Emam, W. Klement, B. Malin: "Reporting and Methodological Observations on Prognostic and Diagnostic Machine Learning Studies". JMIR AI, 2:e47995, 2023.
K. El Emam, B. Malin: "Introducing JMIR AI". JMIR AI, 1:e42046, 2022.
K. El Emam: "Enabling health information sharing with synthetic data." Privacy Law & Business, December 2021.
|K. El Emam: "Could Synthetic Data Be the Future of Data Sharing?" CPO Magazine, August 25, 2021.|
|K. El Emam and R. Boardman: “Are Clinical Trial Data Shared by the EMA Under Policy 0070 Really Public Data?”, Applied Clinical Trials, June 25, 2018.|
|K. El Emam: “A Privacy Framework for Big Data Analytics in Public Health.” In Global Health and Diplomacy, Winter 2015.|
|A. Cavoukian and K. El Emam: “Dispelling the Myths Surrounding De-identification: Anonymization Remains a Strong Tool for Protecting Privacy.” In Canadian Privacy Law Review 8(9), August 2011.|
|B. Pascal, K. El Emam, and M. McCarrey: “Public Accountability and Transparency: the Missing Piece of the Privacy Puzzle.” In Healthcare Information Management and Communications Canada 24(4), December 2009.|
|K. El Emam: “Protecting personal information through anonymization: An overview.” In Cutter IT Journal, November 2006.|
|K. El Emam: “Industrial Evolution”. International Clinical Trials, Spring 2006.|
|D. Barnes and K. El Emam: “Pain Point in Clinical Trials: Mitigating the Risk.” In Biotechnology Focus, March 2006.|
K. El Emam: “Synthetic Data” Un-redacted, The Sask IPC Podcast hosted by Ron Kruzeniski, 2022.
K. El Emam: “Replica Analytics” Privacy Tech Talk hosted by Carlos Chalico and Fahad Diwan, May 18, 2022.
K. El Emam: "A Synthetic Data Deep Dive: Privacy Protector, Foe or Other?” Data Security & Privacy hosted by Rebecca Herold, February 5, 2022.
K. El Emam: "Real or Fake: The buzz about synthetic data". Info Matters podcast, January 18, 2022.
|K. El Emam: "Deciphering Deep Fakes & Synthetic Data". That Tech Pod, November 16, 2021.|
K. El Emam: “Precaution, ethics and risk: Perspectives on regulating non-identifiable data”, IAPP Privacy Advisor, May 24, 2022.
K. El Emam: “Five barriers to the commercialization of medical AI research”, The Hill Times, March 30, 2022.
K. El Emam and M. Hintze: "10 recommendations for regulating non-identifiable data", IAPP Privacy Advisor, September 28, 2021.
|K. El Emam: “Accelerating AI with synthetic data”, IAPP Privacy Tech, February 26, 2020.|
|K. El Emam and M. Hintze: “Does anonymization or de-identification require consent under the GDPR?”, IAPP Privacy Advisor, January 2019.|
|K. El Emam and M. Hintze: “Are there risks of using public clinical trial data under GDPR?”, IAPP Privacy Advisor, July 2018.|
|K. El Emam: “Setting the record straight on privacy dimensions in big data.” IAPP Privacy Tech, June 2, 2016.|
|K. El Emam, T. Jefferson, P. Doshi: “Maximizing the value of clinical study reports.” The BMJ; August 27, 2015.|
|D. Barth-Jones, K. El Emam, J. Bambauer, A. Cavoukian, B. Malin: “Assessing data intrusion threats” (Letter). In Science 2015; 348(6231):194-5.|
|K. El Emam: “On Re-identification: Not really unique in the shopping mall.” IAPP Privacy Tech, February 20, 2015.|
|K. El Emam: “Is it Safe to Anonymize Data?” The BMJ Blogs, February 6, 2015.|
|K. El Emam: “Ten Tips for Privacy Officers on How to Monetize Health Data Responsibly” IAPP Privacy Perspectives, January 9, 2015.|
|K. El Emam: “What are the Privacy Concerns when Sharing Clinical Trial Data?” The BMJ Blogs, December 19, 2014.|
|K. El Emam: “Towards Standards for Anonymizing Clinical Trials Data”, The BMJ Blogs, December 5, 2014.|
|K. El Emam: “Pseudonymous Data is Not Anonymous Data”, The BMJ Blogs, November 20, 2014.|
|K. El Emam: “Public Health Surveillance and Privacy in the Age of Ebola”, IAPP Privacy Perspectives, November 18, 2014.|
|A. Cavoukian, A. Dix, K. El Emam: “Consent and Personal Control are Not Things of the Past”, IAPP Privacy Perspectives, January 8, 2014.|
|K. El Emam: “Anonymisation and Creepy Analytics”, The BMJ Blogs, October 22, 2013.|
|K. El Emam: “Quality models.” Software Quality 1(2), 2005.|
|K. El Emam: “Perspectives on software quality.” Software Quality 1(1), 2004.|
|K. El Emam and S. Rai: “Evaluating predictions of faulty software using thresholds.” In the Annual Conference of the Statistical Society of Canada, 2000.|
|K. El Emam and P. Fusaro: “News Column: Fraunhofer – Institute for Experimental Software Engineering.” In Software Process Improvement and Practice Journal 3(1), 1997.|
|L. Briand and K. El Emam: “Software engineering R&D group at CRIM.” In Software Process Improvement and Practice Journal 2(1), 1996.|
|K. El Emam, B. Shostak, and L. Briand: “Centre de recherche informatique de Montreal (News).” In Software Process Improvement and Practice Journal, 2(2), 1996.|
|K. El Emam and D. R. Goldenson: “Some initial results from the international SPICE trials.” In Software Process Newsletter, IEEE Technical Council on Software Engineering No. 6, Spring 1996.|
|L. Briand and K. El Emam: “Some issues in software engineering data analysis.” In the PERFECT Newsletter, 1995.|